Rymo Technologies Raises ₹10 Crore Seed Round to Take Indian Robotic Neuro-Rehabilitation Global
What is the news?
Rymo Technologies, a pioneering healthcare technology startup co-founded by Chirag Shah and Abhishek Rai, has successfully raised over ₹10 crore in a seed funding round. The investment was led by the IAN Angel Fund (part of the IAN Group), marking a significant milestone for the Navi Mumbai-based firm. Rymo specializes in transforming physical rehabilitation through a sophisticated blend of robotics, virtual reality, and artificial intelligence. Their flagship “Mobi-L” system is designed to help patients recovering from strokes and neurological disorders regain mobility through objective, goal-based therapy.
Why is it interesting?
The fresh infusion of capital is earmarked for aggressive growth. Beyond strengthening its domestic presence in India, Rymo is set to scale its operations into international corridors, specifically targeting the ASEAN and Middle East markets. The company’s “price-performance” advantage allows it to offer advanced robotic therapy at a fraction of the cost of traditional global systems, making it a viable solution for mid-sized hospitals and clinics worldwide. With over 452 device installations already completed and clinical validation studies underway in Italy, Rymo is a prime example of an Indian startup building world-class intellectual property for a global audience.
Read more: Neuro-rehabilitation startup Rymo Technologies secures Rs 10 Cr in seed round